Endocytosis and Exocytosis

Spec mapping: AQA 7402 Section 3.2.3 — bulk transport across membranes (refer to the official AQA specification document for exact wording).

Many of the materials a cell needs to import or export are too large or too polar to cross the cell surface membrane through channel or carrier proteins. Proteins, lipid droplets, microbial pathogens, neurotransmitters, hormones, and cellular debris are all transported by vesicle-mediated trafficking — endocytosis brings them in, exocytosis sends them out. Both processes are integral to immune defence (phagocytosis of pathogens, antibody secretion), neural signalling (neurotransmitter release at synapses), endocrine function (insulin secretion), and lipid metabolism (LDL cholesterol uptake). Both consume ATP and rely on the cytoskeleton and SNARE-protein machinery. This lesson covers the mechanisms, biological significance and clinical relevance of vesicle trafficking — building on the secretory pathway introduced in lesson 1 and setting up the phagocytosis and antibody-secretion themes that recur throughout the immunity lessons (7–9).

Key Definition: Endocytosis is the process by which cells take in materials from outside the cell by engulfing them in a portion of the cell surface membrane, forming a vesicle. Exocytosis is the reverse: intracellular vesicles fuse with the cell surface membrane and release their contents to the outside.

---

Endocytosis

Endocytosis is an active process that requires ATP. It can be divided into three main types.

1. Phagocytosis ('Cell Eating')

Phagocytosis involves the engulfment of large solid particles or entire cells (e.g., bacteria, dead cells, cellular debris).

Steps:

1. The cell detects the target particle, often through receptor proteins on the cell surface that recognise molecules on the particle's surface (e.g., opsonins — antibodies or complement proteins that coat pathogens).
2. The cell extends pseudopodia (extensions of the cytoplasm surrounded by membrane) around the particle.
3. The pseudopodia surround the particle completely, and the membrane fuses to form a large intracellular vesicle called a phagosome (or phagocytic vacuole).
4. Lysosomes fuse with the phagosome, releasing hydrolytic enzymes into the vesicle. This forms a phagolysosome.
5. The enzymes digest the contents of the phagosome. Useful molecules (e.g., amino acids, sugars) are absorbed into the cytoplasm; indigestible residues may be expelled by exocytosis.

Biological significance:

• Neutrophils and macrophages (types of white blood cell) use phagocytosis to destroy invading pathogens as part of the non-specific immune response.
• Amoeba and other protoctists use phagocytosis to engulf food particles.
• In the body, phagocytosis helps clear dead cells and cellular debris during tissue repair and remodelling.

Exam Tip: You may be asked to explain why phagocytosis is described as an active process. The extension of pseudopodia requires ATP-driven rearrangement of the actin cytoskeleton, and the fusion of membranes also requires energy.

2. Pinocytosis ('Cell Drinking')

Pinocytosis involves the uptake of small droplets of extracellular fluid along with any dissolved solutes.

• The cell membrane invaginates (folds inward) to form small vesicles (typically 0.1–0.2 µm in diameter) that pinch off into the cytoplasm.
• Pinocytosis is relatively non-specific — the vesicle takes in whatever solutes happen to be dissolved in the fluid.
• It occurs continuously in many cell types, allowing the cell to sample the extracellular environment.
• Pinocytosis is particularly active in cells lining blood capillaries (endothelial cells), facilitating the transcytosis of substances across the capillary wall.

3. Receptor-Mediated Endocytosis

This is the most specific form of endocytosis and allows cells to take in particular molecules with high efficiency.

Steps:

1. Specific ligands (e.g., LDL cholesterol particles, transferrin carrying iron, certain hormones, growth factors) bind to receptor proteins on the cell surface.
2. The receptor–ligand complexes accumulate in specialised regions of the membrane called clathrin-coated pits — areas where the protein clathrin forms a lattice on the cytoplasmic side of the membrane, helping to shape the vesicle.
3. The coated pit invaginates and pinches off to form a clathrin-coated vesicle containing the concentrated ligands.
4. Inside the cell, the clathrin coat is removed (uncoated), and the vesicle may fuse with an endosome (a sorting compartment).
5. In the endosome, the ligand may be separated from its receptor. The receptor is often recycled back to the cell surface in a recycling vesicle. The ligand may be directed to lysosomes for processing or may be used directly by the cell.

Example — LDL cholesterol uptake:

• Low-density lipoprotein (LDL) particles carry cholesterol in the blood.
• LDL binds to LDL receptors on liver cells and other cell types.
• The receptor–LDL complex is internalised by receptor-mediated endocytosis.
• In the lysosome, the LDL particle is broken down, releasing cholesterol for use in membrane synthesis or steroid hormone production.
• Individuals with familial hypercholesterolaemia have defective LDL receptors, leading to high blood cholesterol and increased risk of cardiovascular disease.

Exam Tip: Receptor-mediated endocytosis is highly efficient because receptors concentrate the target molecule into clathrin-coated pits, allowing uptake even when the molecule is at low concentration in the extracellular fluid.

---

Exocytosis

Exocytosis is the process by which intracellular vesicles fuse with the cell surface membrane and release their contents to the extracellular space. It is an active process requiring ATP.

Steps:

1. Proteins (or other molecules) are synthesised on ribosomes bound to the RER.
2. The proteins enter the RER lumen, where they are folded and may undergo initial modifications.
3. Transport vesicles bud off from the RER and travel to the Golgi apparatus.
4. In the Golgi, the proteins are further modified (e.g., glycosylation, phosphorylation), sorted, and packaged into secretory vesicles that bud off from the trans face.
5. The secretory vesicles are transported along microtubules of the cytoskeleton to the cell surface membrane.
6. The vesicle membrane fuses with the cell surface membrane (a process mediated by SNARE proteins — soluble N-ethylmaleimide-sensitive factor attachment protein receptors).
7. The contents are released to the extracellular space. The vesicle membrane is incorporated into the cell surface membrane, increasing its surface area (this is balanced by endocytosis, which removes membrane).

Types of Exocytosis

• Constitutive exocytosis — occurs continuously, delivering membrane proteins, lipids, and extracellular matrix components to the cell surface. Not regulated by external signals.
• Regulated exocytosis — occurs only in response to a specific signal (e.g., a rise in intracellular Ca²⁺ concentration or a hormone signal). Examples include:
  • Neurotransmitter release at synapses: an action potential causes Ca²⁺ to enter the presynaptic terminal, triggering vesicle fusion and release of neurotransmitter (e.g., acetylcholine) into the synaptic cleft.
  • Insulin secretion from pancreatic β-cells: rising blood glucose triggers exocytosis of insulin-containing secretory granules.
  • Digestive enzyme secretion from pancreatic acinar cells: vesicles containing zymogen granules (inactive enzyme precursors) fuse with the apical membrane and release their contents into the pancreatic duct.

---

The Role of the Golgi Apparatus in Vesicle Transport

The Golgi apparatus is central to the vesicle-mediated transport system:

• It receives proteins and lipids from the ER in transport vesicles.
• It modifies, sorts, and packages these molecules.
• It produces three main types of vesicle from its trans face:
  1. Secretory vesicles — for exocytosis (constitutive or regulated).
  2. Lysosomal vesicles — containing hydrolytic enzymes destined for lysosomes.
  3. Membrane vesicles — carrying membrane proteins and lipids to the cell surface membrane or other organelle membranes.

Exam Tip: The Golgi can be thought of as the cell's 'post office' — it receives parcels (from the ER), processes them, labels them with a 'destination tag' (e.g., a mannose-6-phosphate tag directs enzymes to lysosomes), and dispatches them in vesicles.

---

Membrane Recycling

Endocytosis and exocytosis are balanced processes that maintain the overall surface area of the cell membrane:

• Exocytosis adds membrane to the cell surface (as vesicle membrane is incorporated).
• Endocytosis removes membrane from the cell surface (as vesicles are pinched off inwards).
• This dynamic recycling allows the cell to maintain a constant membrane area while continuously exchanging materials.
• In some cells, membrane recycling occurs rapidly — a macrophage can internalise the equivalent of its entire cell surface membrane in approximately 30 minutes, yet its surface area remains constant because exocytosis replaces the lost membrane.

Quantitative perspective

Consider a secretory cell exocytosing 1000 vesicles per minute, each with surface area ~0.5 µm². Over an hour, the cell would deliver 30 000 µm² of membrane to the surface — many times the typical cell's surface area. Without compensatory endocytosis, the cell would balloon. The reciprocal endocytic rate, removing approximately the same membrane area per unit time, maintains steady state. The implication: at any instant, a substantial fraction of cellular membrane is in transit between the cell surface and intracellular compartments. The "cell surface membrane" is not a static structure but a dynamic flux equilibrium.

---

Transcytosis

Transcytosis is a specialised process combining endocytosis and exocytosis to transport molecules across a cell:

1. A substance is taken into the cell by endocytosis on one side.
2. The vesicle travels across the cell.
3. The vesicle fuses with the membrane on the opposite side, releasing the substance by exocytosis.

This occurs in endothelial cells lining blood capillaries, allowing large molecules (e.g., antibodies, albumin) to cross the capillary wall from blood to tissue fluid.

Examples of transcytosis

• IgA secretion across gut epithelium. The polymeric immunoglobulin receptor binds dimeric IgA produced by plasma cells in the lamina propria, the complex is endocytosed at the basolateral surface, trafficked across the cell, and released at the apical surface as secretory IgA into the gut lumen — a key mucosal defence.
• Maternal IgG transfer to foetus. The neonatal Fc receptor (FcRn) on placental syncytiotrophoblast binds maternal IgG, transports it across the placenta, and releases it into foetal circulation, providing passive immunity covered in lesson 9.
• Blood–brain barrier. Some molecules cross the brain capillary endothelium via transcytosis; this is exploited (or evaded) by pharmaceuticals targeting CNS diseases.

---

SNARE Proteins and Vesicle Fusion — Detail

The vesicle fusion step deserves expansion because it is highly examined and clinically relevant.

Mechanism

• A v-SNARE on the vesicle membrane pairs with a t-SNARE on the target membrane.
• The SNARE proteins zip together from N-terminus to C-terminus, forming a four-helix bundle that draws the two membranes into close apposition.
• The energy released by SNARE coiling overcomes the energy barrier for bilayer fusion.
• After fusion, the SNARE complex is disassembled by the ATPase NSF with the cofactor α-SNAP, recycling the SNAREs for further fusion events.

Different SNAREs for different fusions

The cell uses different v-/t-SNARE pairs for different fusion events, providing specificity. For example, the SNAREs used at synaptic vesicle fusion (synaptobrevin, syntaxin, SNAP-25) differ from those used at constitutive secretion or at endosome–lysosome fusion. This explains how vesicles end up at the correct membrane.

Clinical impact

• Botulinum toxin (produced by Clostridium botulinum) is a protease that cleaves specific SNARE proteins (SNAP-25, syntaxin), preventing neurotransmitter release at neuromuscular junctions. Result: flaccid paralysis. Used therapeutically (Botox) in low doses for muscle spasm, hyperhidrosis, cosmetic indications.
• Tetanus toxin cleaves synaptobrevin on inhibitory interneurones, preventing release of inhibitory neurotransmitters. Result: spastic paralysis.

The two toxins are among the most potent biological molecules known — picograms can kill — and their molecular targets illustrate the importance of SNARE-mediated fusion.

---

Vesicle Recycling at Synapses — A Quantitative Example

At the neuromuscular junction, a single action potential triggers exocytosis of ~100–200 synaptic vesicles, each releasing ~10 000 molecules of acetylcholine. After fusion, the vesicle membrane is rapidly retrieved by clathrin-mediated endocytosis (and possibly faster "kiss-and-run" recycling), refilled with neurotransmitter by V-ATPase-driven proton gradient and acetylcholine transporters, and made ready for the next release. The cycle time can be under 30 seconds for a single vesicle.

This recycling is essential because:

• Neurones must sustain firing rates of 10–100 Hz, requiring rapid vesicle turnover.
• The presynaptic terminal cannot store all the vesicles it might need; it must continuously regenerate them.
• Failure of vesicle recycling causes presynaptic depression — neurotransmission fades.

Several neurological diseases involve defects in vesicle recycling — Parkinson's disease (α-synuclein aggregation impairs vesicle trafficking), Huntington's disease, some forms of epilepsy. Therapeutic strategies targeting vesicle recycling are an active research area.

---

Autophagy